News

Hydrogen Optimized Advances Large-Scale Green Hydrogen Technology with Demonstration of World’s Highest-Current Water Electrolyser

$22 million program achieves significant milestone on path to developing world’s largest Green Hydrogen production systems Owen Sound, Ont. (Oct. 26, 2021) – Hydrogen Optimized, a subsidiary of KEY DH Technologies Inc., today announced that it has completed a demonstration of the world’s highest-current water electrolyser since the 1980s. The operation of a 50,000 ampere… Continue reading →

    Start the Conversation

    SDTC Grant to KEY DH Technologies Enables $12 Million Green Hydrogen Technology Demonstration

    Funds will accelerate commercialization of KEY’s multi-hundred MW Green Hydrogen production systems and significantly reduce carbon emissions (Owen Sound, Ontario – June 8, 2021) – KEY DH Technologies Inc. (KEY) today announced that Sustainable Development Technology Canada (SDTC) has awarded the company a $4.8 million grant in support of a $12 million project to demonstrate… Continue reading →

      Start the Conversation

      Strategic Appointments Announced to KEY DH Technologies Board of Directors to Drive Green Hydrogen Business

      Appointment of veteran leaders in technology and renewable energy industries, and a leading hydrogen industry lawyer position KEY for future growth OWEN SOUND, ON / KEY DH Technologies Inc. (KEY) today announced the appointment of three new independent directors to the company’s board, increasing its size to seven members. With these additions, KEY is well-positioned to… Continue reading →

        Start the Conversation

        Université de Sherbrooke and deutraMed, a KEY DH Technologies’ Subsidiary, Accelerate $500,000 mRNA Vaccine Stabilization Technology Project

        Posted on May 21, 2021 Collaboration seeks to alleviate cold storage requirements for mRNA COVID vaccines, enhance other medical therapeutics (Sherbrooke, Que. and Collingwood, Ont., May 21, 2021) – Université de Sherbrooke and KEY DH Technologies Inc. subsidiary deutraMed Inc. today announced a collaboration to accelerate the development of deutraMed’s innovative Biomolecule Stabilization Technology platform. The… Continue reading →

          Start the Conversation